Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
20.03
+1.02 (5.37%)
May 13, 2025, 4:00 PM - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $982.79 million as of May 14, 2025. Its market cap has increased by 25.13% in one year.
Market Cap
982.79M
Enterprise Value
669.35M
1-Year Change
25.13%
Ranking
Category
Stock Price
$20.03
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $982.79M, an increase of 0.90%. That is a compound annual growth rate of 0.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 932.74M | -15.15% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |